Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Perner

Showing results (171-180 of 283) with videos related to

Pageof 29
Sort By:
Digestion|October 19, 2013
Fibroblast growth factor receptor 1 as a putative therapy target in colorectal cancerFriederike Göke, Antonia Göke, Anne von Mässenhausen, et al.
The Prostate|November 26, 2009
Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivoIsla P Garraway, Wenyi Sun, Chau P Tran, et al.
Urology|December 19, 2009
ERG rearrangement metastasis patterns in locally advanced prostate cancerSven Perner, Maria A Svensson, Ruhella R Hossain, et al.
The American Journal of Pathology|November 7, 2017
Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell CarcinomaRosemarie Krupar, Matthias G Hautmann, Ravi R Pathak, et al.
Histopathology|June 29, 2011
Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancerMartin Braun, Veit J Scheble, Roopika Menon, et al.
Cancers|September 28, 2021
PD-L1 Dependent Immunogenic Landscape in Hot Lung Adenocarcinomas Identified by Transcriptome AnalysisJutta Kirfel, Christiane Charlotte Kümpers, Anke Fähnrich, et al.
Life Science Alliance|May 17, 2024
The F-actin bundler SWAP-70 promotes tumor metastasisChao-Yuan Chang, Glen Pearce, Viktoria Betaneli, et al.
Neurological Research and Practice|October 12, 2021
Paraneoplastic encephalomyeloradiculits with multiple autoantibodies against ITPR-1, GFAP and MOG: case report and literature reviewAnna Cirkel, Klaus-Peter Wandinger, Claudia Ditz, et al.
Oncotarget|December 16, 2016
MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signalingAnne Offermann, Ignacija Vlasic, Isabella Syring, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2009
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?Jennifer R Stark, Sven Perner, Meir J Stampfer, et al.
Pageof 29

Showing results (171-180 of 283) with videos related to

Sort By:
Pageof 29
Digestion|October 19, 2013
Fibroblast growth factor receptor 1 as a putative therapy target in colorectal cancerFriederike Göke, Antonia Göke, Anne von Mässenhausen, et al.
The Prostate|November 26, 2009
Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivoIsla P Garraway, Wenyi Sun, Chau P Tran, et al.
Urology|December 19, 2009
ERG rearrangement metastasis patterns in locally advanced prostate cancerSven Perner, Maria A Svensson, Ruhella R Hossain, et al.
The American Journal of Pathology|November 7, 2017
Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell CarcinomaRosemarie Krupar, Matthias G Hautmann, Ravi R Pathak, et al.
Histopathology|June 29, 2011
Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancerMartin Braun, Veit J Scheble, Roopika Menon, et al.
Cancers|September 28, 2021
PD-L1 Dependent Immunogenic Landscape in Hot Lung Adenocarcinomas Identified by Transcriptome AnalysisJutta Kirfel, Christiane Charlotte Kümpers, Anke Fähnrich, et al.
Life Science Alliance|May 17, 2024
The F-actin bundler SWAP-70 promotes tumor metastasisChao-Yuan Chang, Glen Pearce, Viktoria Betaneli, et al.
Neurological Research and Practice|October 12, 2021
Paraneoplastic encephalomyeloradiculits with multiple autoantibodies against ITPR-1, GFAP and MOG: case report and literature reviewAnna Cirkel, Klaus-Peter Wandinger, Claudia Ditz, et al.
Oncotarget|December 16, 2016
MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signalingAnne Offermann, Ignacija Vlasic, Isabella Syring, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2009
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?Jennifer R Stark, Sven Perner, Meir J Stampfer, et al.
Pageof 29